OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(6)
Omics type
Unknown
(6)
Release Date
2021
(2)
2013
(1)
2012
(1)
2010
(1)
2008
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
0
0
0 Views
0
0 Connections
0
0 Citations
0
0 Reanalyses
0
0 Downloads
Omics score:
0
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
Not available
S-EPMC3354734
|
biostudies-literature
Cite
0
0
0 Views
0
0 Connections
0
0 Citations
0
0 Reanalyses
0
0 Downloads
Omics score:
0
Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsenin
g
of diabetic retinopathy in a randomized clinical trial.
Not available
S-EPMC4162127
|
biostudies-literature
Cite
0
0
0 Views
0
0 Connections
0
0 Citations
0
0 Reanalyses
0
0 Downloads
Omics score:
0
Randomized trial evaluatin
g
ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Not available
S-EPMC2937272
|
biostudies-literature
Cite
0
0
0 Views
0
0 Connections
0
0 Citations
0
0 Reanalyses
0
0 Downloads
Omics score:
0
Machine learnin
g
risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score.
Not available
S-EPMC8344569
|
biostudies-literature
Cite
0
0
0 Views
0
0 Connections
0
0 Citations
0
0 Reanalyses
0
0 Downloads
Omics score:
0
Death followin
g
pulmonary complications of surgery before and during the SARS-CoV-2 pandemic.
Not available
S-EPMC10364875
|
biostudies-literature
Cite
0
0
0 Views
0
0 Connections
0
0 Citations
0
0 Reanalyses
0
0 Downloads
Omics score:
0
A randomized trial comparin
g
intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
Not available
S-EPMC2748264
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets